Skip to content
Intelligibberish
  • News
  • Articles
  • Guides
  • Tools
  • About

Category

Analysis

← All articles

Analysis Feb 27, 2026

ElevenLabs Hits $11 Billion Valuation as Voice AI Goes Enterprise

The voice AI startup tripled its valuation to $11B on $330M ARR. Enterprise adoption is driving the surge.

Analysis Feb 27, 2026

Meta Pushed Llama 4 Out the Door Over Safety Team Objections

Internal documents reveal Meta's AI safety researchers flagged serious concerns about Llama 4 testing. Leadership released the model anyway.

Analysis Feb 27, 2026

Microsoft Copilot Tasks Spins Up Its Own Cloud PC to Do Your Work

Microsoft's new agentic AI feature creates a virtual computer in the cloud to execute multi-step tasks while you do other things. It's impressive - and raises familiar questions.

Analysis Feb 27, 2026

AI Maps Cause-and-Effect Gene Networks in Alzheimer's for First Time

SIGNET platform identifies hub genes driving brain cell rewiring, opening new paths for early diagnosis and treatment.

Analysis Feb 27, 2026

VCs Abandon Loyalty, Bet on Both OpenAI and Anthropic Simultaneously

At least a dozen OpenAI investors now back Anthropic too. The traditional VC taboo against funding rivals is collapsing.

Analysis Feb 26, 2026

The AI Business Model Split: Why Your Chatbot Wants to Sell You Things

OpenAI launched ChatGPT ads this month. Perplexity abandoned them. Anthropic ran a Super Bowl campaign mocking the whole concept. The business model divergence reveals deeper questions about what AI assistants are actually for.

Analysis Feb 26, 2026

The Great Unwiring: How AI Is Rewiring Students' Ability to Think

A Brookings study across 50 countries warns AI is causing 'cognitive atrophy' in students. Teachers report kids who can't reason or solve problems.

Analysis Feb 26, 2026

Anthropic Abandons Core Safety Pledge as Pentagon Ultimatum Looms

The company founded to build safe AI has quietly dropped its promise to halt development if risks outpace safeguards. The timing - one day before a Pentagon deadline - raises uncomfortable questions.

Analysis Feb 26, 2026

First AI-Designed Drug Shows Real Results in Human Trial

Insilico Medicine's rentosertib improved lung function in IPF patients, marking the first clinical validation of AI-driven drug discovery.

Analysis Feb 26, 2026

MatX Raises $500M to Build an Nvidia Killer, Claims 10x Better LLM Performance

Google TPU veterans land major funding from Jane Street and Leopold Aschenbrenner's fund to develop chips shipping in 2027

Analysis Feb 26, 2026

Meta's AI Alignment Director Told Her Agent to Stop. It Didn't.

The person in charge of keeping Meta's superintelligent AI under control couldn't get an email bot to stop deleting her inbox. This is either hilarious or terrifying.

Analysis Feb 26, 2026

Nvidia Smashes Q4 with $68 Billion Revenue, Declares 'Agentic AI Inflection Point'

The chipmaker beats Wall Street expectations again, announces Vera Rubin platform promising 10x better inference, but stock dips anyway

Analysis Feb 26, 2026

Stanford-Harvard Report Finds Clinical AI Isn't Living Up to the Hype

Only 5% of medical AI studies use real patient data. A new report documents the gap between lab performance and hospital reality.

Analysis Feb 25, 2026

AI Agent Teams Are Running Biomedical Research Autonomously

Nature Biotechnology paper describes 'in silico team science' where AI agent collectives handle literature review, hypothesis generation, and data analysis

Analysis Feb 25, 2026

Google+UVA: Longer Reasoning Predicts Failure, Not Success

Google and UVA research shows longer AI reasoning traces correlate with wrong answers. The fix: measure how deeply the model thinks, not how much it writes.

Analysis Feb 25, 2026

Meta's $100B AMD Deal: Breaking Free from Nvidia to Chase 'Personal Superintelligence'

Meta commits up to $100 billion to AMD chips over five years, gaining a 10% stake option and reducing Nvidia dependence as Zuckerberg pursues AI for everyone

Analysis Feb 25, 2026

MIT's AI-Designed Sensors Could Detect 30 Cancers With a Urine Test

CleaveNet system designs peptide sensors that detect cancer-linked enzymes, potentially enabling at-home screening for dozens of cancer types

Analysis Feb 25, 2026

OpenAI Defeats xAI Trade Secrets Lawsuit as Judge Finds No Evidence of Wrongdoing

Federal judge dismisses Elon Musk's xAI lawsuit against OpenAI, ruling that hiring former employees isn't theft - but the AI talent wars continue

Analysis Feb 25, 2026

Pentagon Gives Anthropic 72-Hour Ultimatum: Drop AI Safety Guardrails or Face Defense Production Act

After a tense Tuesday meeting, Defense Secretary Hegseth told Anthropic's CEO: comply by Friday 5pm or the government will force compliance. Anthropic isn't budging.

Analysis Feb 24, 2026

AI Chatbots Analyzed Medical Data Faster Than Human Teams, UCSF Study Finds

Half of the tested AI tools produced prediction models that matched or beat human researchers. A master's student and high schooler built working code in minutes.

Analysis Feb 24, 2026

The People Building AI Keep Quitting and Warning Us

OpenAI dissolves its mission alignment team while senior researchers exit Anthropic, OpenAI, and xAI citing safety concerns

Analysis Feb 24, 2026

AI Startups Are Worth Billions Before They Build Anything

Over half of US seed and Series A funding now goes to $100M+ rounds as investors bet on pedigree over products

Analysis Feb 24, 2026

The 'Anthropic Effect': Claude Code Crashes IBM 13%, Triggers Cybersecurity Bloodbath

Anthropic's COBOL modernization playbook and security tool preview wipe $45 billion from tech stocks in a single day

Analysis Feb 24, 2026

Big Tech's $650 Billion AI Gamble Is Draining Their Cash Reserves

Amazon, Google, Meta, and Microsoft are spending record amounts on AI infrastructure while their free cash flow craters

← Newer15 / 19Older →
Intelligibberish

Making sense of AI overwhelm. Independent, self-hosted, no trackers.

News Articles Guides Tools About Disclosure Privacy RSS

© 2026 Intelligibberish. Making sense of AI overwhelm.